Jonathan Biller

Jonathan Biller appears in 51 filings published between December 18, 2018 and February 26, 2026, split between Vertex Pharmaceuticals INC / MA (31, as EVP and Chief Legal Officer), Agios Pharmaceuticals, Inc. (10, as Chief Financial Officer) and Celgene Corp /DE/ (10, as EVP AND GENERAL COUNSEL). No purchase appears.

The 12 sales total EUR 6,989,238, with a median of EUR 457,308. The three largest, all at Vertex, are worth EUR 1,532,524 (February 11, 2025), EUR 1,022,713 (February 17, 2026) and EUR 745,464 (February 11, 2026): three February dates. The record also counts 28 grants, 8 option exercises and 3 other filings.

The yearly volume grows over time: 2 filings in 2018 and in 2021, 8 in 2019, 6 in 2024, 9 in 2025 and 12 so far in 2026. A total of 13 filings fall in the last twelve months, 6 of them sales.

At Vertex, Edward Morrow Atkinson III and Ourania Tatsis each have 9 trades within 30 days of a market trade by Biller, Kristen Ambrose 8, on the same side. Filings are published a median of 2 days after the trade.